"Astex's unique fragment-based drug discovery technology [Ed: emphasis added] and clinical oncology research and development capabilities, born out of the passion of its researchers, exemplify our corporate mottos and belief in "Sozosei (Creativity) and Jissho (Proof through Execution). I would like Otsuka Pharmaceutical to continue to respect Astex's uniqueness and leverage it to bring further growth for Otsuka Pharmaceutical."
This blog is meant to allow Fragment-based Drug Design Practitioners to get together and discuss NON-CONFIDENTIAL issues regarding fragments.
05 September 2013
What Do Fragments Get you?
Parroting In the Pipeline, what do fragments get you? 886 Million dollars, that's what! As pointed out by the buying company:
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment